Key regions: Australia, Italy, France, South Korea, Brazil
The demand for vaccines in Tajikistan has been on the rise in recent years due to various factors.
Customer preferences: Tajikistan has a high infant mortality rate, which has led to an increase in demand for vaccines. Parents are now more aware of the importance of vaccinating their children to prevent diseases and protect them from life-threatening illnesses. Additionally, the government has been actively promoting vaccination programs, which has contributed to the increase in demand for vaccines.
Trends in the market: The vaccines market in Tajikistan is expected to grow at a steady pace in the coming years. The demand for vaccines is expected to increase due to the government's efforts to promote vaccination programs, the high infant mortality rate, and the increasing awareness among the population about the importance of vaccination. The market is expected to witness growth in both the public and private sectors.
Local special circumstances: Tajikistan is a landlocked country in Central Asia with a population of over 9 million people. The country has a high infant mortality rate, which is one of the highest in the region. The country also has a high incidence of infectious diseases, such as tuberculosis, hepatitis, and HIV/AIDS. The government has been working to address these issues by promoting vaccination programs and improving healthcare facilities across the country.
Underlying macroeconomic factors: Tajikistan is a low-income country with a developing economy. The country's healthcare sector is still in the process of development, and the government has been making efforts to improve the healthcare infrastructure and provide better access to healthcare services. The government has also been working to attract foreign investment in the healthcare sector, which is expected to contribute to the growth of the vaccines market in the country. Additionally, the country's strategic location makes it an attractive market for pharmaceutical companies looking to expand their operations in Central Asia.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
